1. Torphy, Robert J, Sun, Yi, Lin, Ronggui, Kedl, Ross M, Zhu, Yuwen. 2022. GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models. In Nature communications, 13, 97. doi:10.1038/s41467-021-27658-x. https://pubmed.ncbi.nlm.nih.gov/35013216/
2. Kechele, Daniel O, Blue, R Eric, Zwarycz, Bailey, Lund, P Kay, Caron, Kathleen M. 2017. Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formation. In The Journal of clinical investigation, 127, 593-607. doi:10.1172/JCI87588. https://pubmed.ncbi.nlm.nih.gov/28094771/
3. de Haan, Willeke, Øie, Cristina, Benkheil, Mohammed, Smedsrød, Bård, Luttun, Aernout. 2020. Unraveling the transcriptional determinants of liver sinusoidal endothelial cell specialization. In American journal of physiology. Gastrointestinal and liver physiology, 318, G803-G815. doi:10.1152/ajpgi.00215.2019. https://pubmed.ncbi.nlm.nih.gov/32116021/
4. Kwon, Hyouk-Bum, Mackie, Duncan I, Bonnavion, Remy, Caron, Kathleen M, Stainier, Didier Y R. 2020. The Orphan G-Protein Coupled Receptor 182 Is a Negative Regulator of Definitive Hematopoiesis through Leukotriene B4 Signaling. In ACS pharmacology & translational science, 3, 676-689. doi:10.1021/acsptsci.0c00020. https://pubmed.ncbi.nlm.nih.gov/32832870/
5. Wang, Yaqi, Gao, Bin, Xia, Chunhua, Liu, Haifeng, Wu, Senlin. 2023. Development of a novel tumor microenvironment-related radiogenomics model for prognosis prediction in hepatocellular carcinoma. In Quantitative imaging in medicine and surgery, 13, 5803-5814. doi:10.21037/qims-22-840. https://pubmed.ncbi.nlm.nih.gov/37711809/